A Phase I/II Study of AST-3424 in Subjects With Advanced Solid Tumors
A Phase I/II Study of AST-3424 in Subjects With Advanced Solid Tumors
Active, not recruiting · NCT06239155 · Registry updated 2025-02-25Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase I/II Study of AST-3424 in Subjects With Advanced Solid Tumors | Digestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, carcinoma, epithelial neoplasm, hepatocellular carcinoma, liver disorder, neoplasm | Active, not recruiting | Phase 1 / Phase 2 | 2025-02-25 | NCT06239155 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Ascentawits Pharmaceuticals, Ltd | 2 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Chinese People's Liberation Army Eastern Theater General Hospital Qinhuai medical District | Nanjing | China | 1 |
| Guangdong Qifu Hospital | Guangzhou | China | 1 |
| Henan Cancer Hospital | Zhengzhou | China | 76 |
| Shanghai East Hospital | Shanghai | China | 11 |
| Sir Run Run Shaw Hospital (SRRSH), affiliated with the Zhejiang University School of Medicine | Hangzhou | China | 1 |
| The First Affiliated Hospital of China Medical University | Shenyang | China | 7 |
| Zhejiang Cancer Hospital | Hangzhou | China | 21 |